We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMAR
776
DELISTED
Smartsheet Inc.
SMAR
$748K 0.01%
16,965
-103
-0.6% -$4.11K
MAT icon
777
Mattel
MAT
$4.33B
$746K 0.01%
45,859
-12,667
-22% -$230K
MSA icon
778
Mine Safety
MSA
$7.34B
$746K 0.01%
3,972
-932
-19% -$173K
LNTH icon
779
Lantheus
LNTH
$6.58B
$745K 0.01%
9,285
-528
-5% -$38.7K
DTM icon
780
DT Midstream
DTM
$13.2B
$741K 0.01%
10,428
-1,123
-10% -$73.7K
ROKU icon
781
Roku
ROKU
$23.4B
$735K 0.01%
12,258
+301
+3% +$17.6K
SAIC icon
782
Saic
SAIC
$5.33B
$734K 0.01%
6,248
-661
-10% -$83.7K
ONB icon
783
Old National Bancorp
ONB
$9.89B
$732K 0.01%
42,568
+542
+1% +$9.01K
VKTX icon
784
Viking Therapeutics
VKTX
$3.75B
$724K 0.01%
13,649
+7,435
+120% +$487K
JAZZ icon
785
Jazz Pharmaceuticals
JAZZ
$15.9B
$723K 0.01%
6,774
-6,418
-49% -$706K
GME icon
786
GameStop
GME
$8.02B
$723K 0.01%
29,274
-2,759
-9% -$54.7K
RL icon
787
Ralph Lauren
RL
$21.1B
$719K 0.01%
4,108
-537
-12% -$92.7K
AM icon
788
Antero Midstream
AM
$10.6B
$718K 0.01%
48,697
-2,223
-4% -$31.9K
QLYS icon
789
Qualys
QLYS
$6.47B
$714K 0.01%
5,008
-312
-6% -$47.5K
HR icon
790
Healthcare Realty
HR
$6.51B
$714K 0.01%
43,309
-6,600
-13% -$101K
CBSH icon
791
Commerce Bancshares
CBSH
$8.32B
$713K 0.01%
14,087
-1,543
-10% -$76.3K
LSTR icon
792
Landstar System
LSTR
$6.11B
$711K 0.01%
3,854
-3,008
-44% -$542K
LEA icon
793
Lear
LEA
$8.26B
$710K 0.01%
6,216
-3,416
-35% -$437K
MIDD icon
794
Middleby
MIDD
$5.1B
$706K 0.01%
5,757
-625
-10% -$84.8K
STAG icon
795
STAG Industrial
STAG
$7.17B
$706K 0.01%
19,566
-2,056
-10% -$73.2K
MMS icon
796
Maximus
MMS
$3.13B
$705K 0.01%
8,223
-549
-6% -$46.1K
AAL icon
797
American Airlines Group
AAL
$9.03B
$702K 0.01%
61,982
-17,810
-22% -$234K
OPCH icon
798
Option Care Health
OPCH
$3.58B
$702K 0.01%
25,328
-1,337
-5% -$39.9K
CADE
799
DELISTED
Cadence Bank
CADE
$699K 0.01%
24,709
-1,508
-6% -$42.4K
KBH icon
800
KB Home
KBH
$3.36B
$693K 0.01%
9,872
-701
-7% -$47.7K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.